Limb-girdle muscular dystrophies



Limb-girdle muscular dystrophy, LGMD, Hereditary myopathies


Hereditary myopathies include a wide range of clinically, biochemically, and genetically distinct muscle diseases. Some of them have been known since the 19th century, and subsequently they have been linked to several hundred pathogenic variants, with new mutations and genes being identified each year. Among them, Limb-girdle- muscular dystrophy (LGMD) is a broad and heterogeneous group of inherited muscle disorders involving weakness of the proximal pelvic or shoulder muscles. The clinical phenotype varies and includes both- severe childhood-onset and milder late-onset forms, in detained individuals have slow progression of muscle weakness and a relatively preserved life course. They are a genetically heterogeneous group where molecular genetic diagnosis still remains a challenge.


[Bozhinov, S., Galabov, G. Klinichno, biohimichno, histologichno, histohimichno I elektronnomikroskopsko izsledvane. Medicina i fizkultura, Sofia, 1973, 24s.]

Milanov, I., Tournev, I., & Chamova, T. (2021). National consensus on diagnosis, treatment and prevention of hereditary neuromuscular disorders. Bulgarian Neurology, 22(S2), 1–35. Retrieved from

Taneva, A., Chamova, T., Bichev, S., Todorov, T., Gospodinova, M., Kastreva, K., Zlatareva, D., Krupev, M., Hadjiivanov, R., Guergueltcheva, V., Grozdanova, L., Tzoneva, D., Huebner, A., Hagen, M. v. der, Schoser, B., Lochmüller, H., Todorova, A., & Tournev, I. (2019). Limb girdle muscular dystrophy 2G in a religious minority of bulgarian muslims homozygous for the c.75g>a, p. trp25x mutation. Bulgarian Neurology, 20(2), 71–76. Retrieved from

Angelini, C., Fanin, M., Menegazzo, E., Freda, P., Duggan, J., Hoffman, P. Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limbgirdle muscular dystrophy patient. Muscle Nerve, 1998, 21, 6, 769-775.

Angelini, C., Fanin, M. Calpainopathy. In: GeneReviews®. University of Washington, Seattle, 1993, 1-30.

Angelini, C., Marina, F. Pathogenesis, clinical features and diagnosis of sarcoglycanopathies, 2016, Expert Opinion on Orphan Drugs.

Barp, A., Laforet, P., Bello, L., Tasca, G., Vissing, J., Monforte, M., Ricci, E., Choumert, A., Stojkovic, T., Malfatti, E., Pegoraro, E., Semplicini, C., Stramare, R., Scheidegger, O., Haberlova, J., Straub, V., Marini-Bettolo, C., Løkken, N., Diaz-Manera, J., Urtizberea, J., Mercuri, E., Kynčl, M., Walter, M., Carlier, R. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A). J Neurol, 2020, 267, 45-56.

Beckmann, S., Richard, I., Hillaire, D., Broux, O., Antignac, C, Bois, E., Cann, H.,Cottingham, W., Feingold, N., Feingold, J. A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C. R. l’Academie Sci. 1991, 3, 312, 141-148.

Bushby, K. Report on the 12th ENMC Sponsored International Workshop – The „Limb-Girdle” Muscular Dystrophies. Neuromuscular Disorders, 1992, 2, 1, 3-5.

Ermolova, N., Kramerova, I., Spencer, J. Autolytic activation of calpain 3 proteinase is facilitated by calmodulin protein. J Biol Chem, 2015, 290, 2, 996-1004.

Fanin, M., Angelini C. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls. Muscle Nerve, 2015, 52, 163-173.

Fichna, J.P., Macias, A., Piechota, M. et al. Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients. Hum. Genomics, 2018, 12, 34.

Forrest, K., Mellerio, J.E., Robb, S., Dopping-Hepenstal, P.J.C., McGrath, J.A., Liu, L., Buk, S.J.A., Al-Sarraj, S., Wraige, E., and Jungbluth, H, Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin. Neuromuscul. Disord. 2010, 20, 709-711.

Gamez, J., Navarro, C., Andreu, L., Fernandez, M., Palenzuela, L., Tejeira, S., et al. Autosomal dominant limb-girdle muscular dystrophy: a large kindred with evidence for anticipation. Neurology, 2001, 56, 4, 450-454.

Georgieva, B., Todorova, A., Tournev. I., Mitev. V., Plageras. P., Kremensky. I. 550delA mutation in the calpain 3 (CAPN3) gene: DMD/BMD, SMA, or LGMD2A – clinically misdiagnosed cases. Am J Med Genet A. 2005, 1, 4, 399-400.

Ishpekova, B., Milanov, I. Differential diagnosis of limb-girdle syndromes. Electromyography and clinical Neurophysiology, 1996, 36, 8, 469-475.

Kirschner, J., Lochmller, H. Sarcoglycanopathies. Hand Clin Neurol, 2011, 101, 41-46.

Liewluck, T., Milone, M. Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve, 2018, 58, 2, 167-177.

Liu, J., Aoki, M., Illa, I., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet, 1998, 20, 31-36.

Malfatti, E., Cassandrini, D., Rubegni, A., et al. Respiratory muscle involvement in HNRNPDL LGMD D3 muscular dystrophy: an extensive clinical description of the first Italian patient. Acta Myol, 2020, 39, 98-100.

Mathews, D., Stephan, M., Laubenthal, K., et al. Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I. Neurology, 2011, 76, 194-195.

Moreira, S., Vainzof, M., Marie, K., Sertié, L., Zatz, M., Passos- Bueno, R. The seventh form of autosomal recessivelimb-girdle muscular dystrophy is mapped to 17q11–12. Am J Hum Genet, 1997, 61, 151-159.

Nigro, V., Savarese, M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol, 2014, 33, 1, 1-12.

Ozawa, E., Noguchi, S., Mizuno, Y., et al. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve, 1998, 21, 421-387.

Palmio, J., Jonson, H., Evilä, A., et al. Novel mutations in DNAJB6 gene cause a very severe early onset limb-girdle muscular dystrophy 1D disease. Neuromuscul Disord, 2015, 25, 835-842.

Penisson-Besnier, I., Hackman, P., Suominen, T., et al. Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. J Neurol Neurosurg Psychiatry, 2010, 81, 1200-1202.

Piccolo, F., Jeanpierre, M., Leturcq, F. et al. A founder mutation in the ɣ-sarcoglycan gene of Gypsies possibly predating their migration out of India. Hum Mol Genet, 1996, 5, 12, 2019-2022.

Pollitt, C., Anderson, V., Pogue, R., Davison, K., Pyle, A., Bushby, M. The phenotype of calpainopathy: Diagnosis based on a multidisciplinary approach. Neuromuscul. Disord, 2001, 11, 287-296.

Santavuori, P., Somer, H., Sainio, K., Rapola, J., Kruus, S., Nikitin, T., Ketonen, L., Leisti, J. Muscle- eye- brain disease (MEB). Brain Dev, 1989, 11, 3, 147-153.

Sarparanta, J., Jonson, H., Golzio, C., et al. Mutations affecting the cytoplasmic functions of the cochaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet, 2012, 44, 450-455.

Savarese, M., Di Fruscio, G., Tasca, G., Ruggiero, L., Janssens, S., De Bleecker, J., Delpech, M., Musumeci, O., Toscano, A., Angelini, C., Sacconi, S., Santoro, L., Ricci, E., Claes, K., Politano, L., Nigro, V. Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations. Neuromuscul Disord, 2015, 25, 7, 533-541.

Servián-Morilla, E., Cabrera-Serrano, M., Johnson, K., Pandey, A., Ito, A., Rivas, E., Chamova, T., Muelas, N., Mongini, T., Nafissi, S., Claeys, G., Grewal, P., Takeuchi, M., Hao, H., Bönnemann, C., Lopes Abath Neto, O., Medne, L., Brandsema, J., Töpf, A., Taneva, A., Vilchez, J., Tournev, I., Haltiwanger, S., Takeuchi, H., Jafar-Nejad, H., Straub, V., Paradas, C. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern. Acta Neuropathol, 2020, 139, 3, 565-582.

Straub, V., Murphy, A., Udd, B., LGMD workshop study group. 229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord, 2018, 28, 8, 702-710.

Thompson, R., Straub, V. Limb-girdle muscular dystrophies – international collaborations for translational research. Nat Rev Neurol, 2016, 12, 294-309.

Todorova, A., Ashikov, A., Beltcheva, O., Tournev, I., Kremensky, I. C283Y mutation and other C-terminal nucleotide changes in the gamma-sarcoglycan gene in the Bulgarian Gypsy population. Hum Mutat, 1999, 14, 1, 40-44.

Tournev, I., Aneva, L., Kamenov, O., Ishpekova, B., Katsarova, M., Gergelcheva, V., Angelicheva D, Kalaydjieva L. Gamma sarcoglycan deficiency in Bulgarian Gypsies. Muscle & Nerve, 1998, 7, 136.

Tsutsumi, S., Kamata, N., Vokes, J., Maruoka, Y., Nakakuki, K., Enomoto, S., Omura, K., Amagasa, T., Nagayama, M., Saito- Ohara, F., Inazawa, J., Moritani, M., Yamaoka, T., Inoue, H., Itakura, M. The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD). Am J Hum Genet, 2004, 74, 6, 1255-1261.

Uitto, J., Pulkkinen, L., Smith, J., McLean, H. Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy. Exp Dermatol, 1996, 5, 5, 237-246.

Van Reeuwijk, J., Olderode-Berends, J., Van den Elzen, C., et al. A homozygous FKRP start codon mutation is associated with Walker–Warburg syndrome, the severe end of the clinical spectrum. Clin Genet, 2010, 78, 275-281.

Vissing, J. Limb girdle muscular dystrophies: classification, clinical specrum and emerging therapies. Curr Opin Neurol. 2016, 29, 635-641.

Vissing, J., Barresi, R., Witting, N., Van Ghelue, M., Gammelgaard, L., Bindoff, LA., et al. A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy. Brain, 2016, 139, 2154-2163.

Walton, N., Nattras, J. On the classification, natural history and treatment of myopathies. Brain, 1954, 77, 2, 169-231.



How to Cite

Taneva, A., Chamova, T., & Tournev, I. (2022). Limb-girdle muscular dystrophies. Bulgarian Neurology, 23(2), 43–52. Retrieved from